BIVALIRUDIN FOR INJECTION
Google image searchProduct monograph
Active ingredient
bivalirudin, 250 MG/VIAL
DIN: 02511452
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: JUNO PHARMACEUTICALS CORP.
Date: 01-MAY-2023
ATC:
- B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
- B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
- B01AE — Direct thrombin inhibitors (ATC, ATC/DDD)
- B01AE06 — BIVALIRUDIN (ATC/DDD)
Reference brand drug: Angiomax
